MAOA Protein

MAOA Protein

Introduction

Maoa Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Monoamine Oxidase A (MAOA) protein is a flavin-containing enzyme located on the mitochondrial outer membrane[@edmondson2021]. It catalyzes the oxidative deamination of monoamine neurotransmitters and is essential for maintaining brain chemistry balance[@shih2021]. The protein is expressed throughout the brain, with high levels in the prefrontal [cortex](/brain-regions/cortex), hippocampus, and limbic system.

MAOA Protein

Introduction

Maoa Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Monoamine Oxidase A (MAOA) protein is a flavin-containing enzyme located on the mitochondrial outer membrane[@edmondson2021]. It catalyzes the oxidative deamination of monoamine neurotransmitters and is essential for maintaining brain chemistry balance[@shih2021]. The protein is expressed throughout the brain, with high levels in the prefrontal [cortex](/brain-regions/cortex), hippocampus, and limbic system.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#f0f0f0;">Monoamine Oxidase A (MAOA)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Monoamine Oxidase A</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/maoa">MAOA</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P21397">P21397</a></td></tr>
<tr><td><strong>PDB ID(s)</strong></td><td>2Z5X, 2BXR, 1O5W</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>59.7 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondrial outer membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Monoamine oxidase family</td></tr>
<tr><td><strong>Cofactor</strong></td><td>FAD (covalently bound)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>Prefrontal cortex, hippocampus, limbic system</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/diabetes" style="color:#ef9a9a">Diabetes</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">69 edges</a></td>
</tr>
</table>
</div>

Structure

Active Site Architecture

• FAD-binding domain: N-terminal region containing the flavin adenine dinucleotide cofactor that is covalently attached to a cysteine residue
• Substrate pocket: Specificity-determining region that distinguishes between different monoamine substrates
• Active site entrance: Controls substrate access and determines substrate affinity
• Membrane-binding region: C-terminal transmembrane helix anchors the protein to the mitochondrial outer membrane

Conformational Features

The enzyme has several distinctive structural features:

• N-terminal coil: Mitochondrial targeting sequence that directs the protein to the mitochondrion
• Catalytic core: Central domain containing the FAD cofactor and substrate-binding site
• Membrane anchor: C-terminal alpha-helical transmembrane segment

Function

Catalytic Mechanism

MAOA catalyzes the oxidative deamination of monoamines through a well-characterized mechanism[@edmondson2021]:

Substrate Specificity

MAOA has broad substrate specificity including:

• Serotonin (5-HT): Primary substrate in the brain, rate-limiting for 5-HT catabolism
• Norepinephrine: Major peripheral substrate affecting autonomic function
• Dopamine: Significant in certain brain regions
• Tyramine: Important for dietary amine metabolism
• Melatonin: Pineal hormone metabolism

Brain Region Distribution

High expression in:

• Prefrontal cortex (cognitive function)
• [Hippocampus](/brain-regions/hippocampus) (memory and learning)
• Amygdala (emotional processing)
• Hypothalamus (autonomic regulation)
• Locus coeruleus (arousal and attention)

Disease Relevance

Neurological Disorders

Alzheimer's Disease

• MAOA activity is elevated in AD brains
• Contributes to oxidative stress
• May affect amyloid metabolism
• Potential therapeutic target[@shih2021]

Parkinson's Disease

• MAOA inhibitors used as adjunct therapy
• Protects dopaminergic [neurons](/entities/neurons)
• Reduces oxidative dopamine metabolism
• May slow disease progression

Depression

• MAOA inhibitors: Historically important antidepressants
• Non-selective: Affects both MAOA and MAOB
• Dietary restrictions: Tyramine-induced hypertension risk

Aggression and Behavioral Disorders

• Brunner syndrome: MAOA deficiency causes impulsive aggression
• Gene-environment interaction: Early life trauma + low MAOA
• Neurodevelopmental effects: Alters brain circuit development

Pharmacological Inhibition

Clinical Inhibitors

| Inhibitor | Type | Clinical Use | Notes |
|-----------|------|--------------|-------|
| Phenelzine | Irreversible | Depression (historical) | Non-selective |
| Clorgyline | Irreversible | Research tool | MAOA-selective |
| Moclobemide | Reversible | Depression (EU, not US) | Dietary restrictions minimal |
| Selegiline | Irreversible | Parkinson's disease | MAO-B selective at low dose |

New Developments

• Neuroprotective strategies: Reduce H₂O₂ production
• Reversible inhibitors: Safer dietary profiles
• Gene therapy approaches: AAV-mediated expression

Molecular Interactions

Protein Partners

• FAD: Covalently bound flavin cofactor
• Hsp70: Chaperone-assisted folding
• Mitochondrial porin: Membrane integration
• Other monoamine oxidases: MAOB (heterodimerization possible)

Pathway Involvement

• Dopamine metabolism pathway
• Serotonin synthesis and degradation
• Neurotransmitter catabolism
• Oxidative stress response

Research Tools

Detection Methods

• Enzyme activity assays: Radiometric, fluorometric
• Immunohistochemistry: Tissue localization
• Western blot: Protein expression analysis
• Real-time PCR: mRNA quantification

Model Systems

• Knockout mice: MAOA-deficient mice show elevated monoamines
• Transgenic overexpression: Human MAOA expression models
• iPSC-derived neurons: Disease modeling

See Also

• [MAOA Gene](/proteins/maoa-protein)
• [Monoamine Oxidase B](/proteins/maob-protein)
• [Dopamine Metabolism](/mechanisms/dopamine-metabolism)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Depression](/diseases/depression)

External Links

• [UniProt: P21397](https://www.uniprot.org/uniprot/P21397)
• [PDB: 2Z5X](https://www.rcsb.org/structure/2Z5X)
• [GeneCards: MAOA](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MAOA)
• [Human Protein Atlas: MAOA](https://www.proteinatlas.org/ENSG00000189221-MAOA)

Background

The study of Maoa Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References